Brampton included in program that will give AstraZeneca-Oxford vaccine to those 60 to 64
Brampton will be part of a pilot project that will allow primary care providers such as pharmacies to administer the AstraZeneca-Oxford vaccine.
Details of the program are expected to be announced later today.
The project will be for those ages 60 to 64.
The AstraZeneca-Oxford vaccine was only just recently approved for use in Canada; however, Canadian health officials have determined that it will be less effective than other vaccines in battling COVID-19 for those over the age of 65.
Because the vaccine has already been purchased by Canada, it was decided to make it available to people between the ages of 60 and 64.
- Mississauga to be part of pilot project involving AstraZeneca-Oxford vaccine
- Ontario pharmacy COVID-19 vaccine pilot to begin next week with Oxford-AstraZeneca
- Ontario health minister will take Oxford-AstraZeneca vaccine to combat hesitancy
- National panel advises against using Oxford-AstraZeneca’s COVID-19 vaccine on seniors
- New U.S. trial confirms Oxford-AstraZeneca COVID-19 vaccine is 79% effective
- Mississauga transit buses now have seats that are unsafe to sit in
- "Don't paint the hydrants" Mississauga fire department tells the public
- Police make arrest in assualt case at a Mississauga park
- Carjacking at knifepoint in Brampton, suspects sought by Peel police
- Pfizer says third dose of COVID-19 vaccine very effective against Delta variant